Next Vial review
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
Next Vial earns a Match Score of 58/100 (grade C) and sits #333 of 497 on our board under the balanced default weighting.
- Semaglutide
- $250/mo (compounded)
- Tirzepatide
- Not disclosed
- Coverage
- 49 states
- Brand-name
- Compounded only
- Oral option
- Injectable only
- Verification
- Not independently listed
Best for: People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
MatchScript's take: Our #333 pick of 497 — a focused, straightforward program, scored on the same six factors as everyone else.
The factor breakdown
Next Vial on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $250/mo (compounded) puts Budget Fit at a below-par 40 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a solid 86 on Speed to Start.
Next Vial sticks to compounded injectables, for a below-par 53 on Formulary Match.
Support lands at a below-par 72 — lighter, meds-first support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
Disclosure here is thinner than the top of the board give a below-par 46 on Transparency.
Pricing in context
How Next Vial's monthly price sits against the category median and the cheapest provider we track.
What we like
- LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
- No membership fees — one all-in price covering consultation, medication, and shipping
- Compounded semaglutide, tirzepatide, and microdose options available
- Free rushed shipping; serves 49 states nationwide
- Board-certified physician oversight with ongoing provider support
The caveats
- Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
- Compounded medications are not FDA-approved
- Labs and nutritional coaching not disclosed
- Microdose pricing not published on product page
- Alaska not listed among served states
Who it's for — and who should skip it
Choose Next Vial if people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
Skip it if that doesn't sound like you. A closer fit may be Ascend Medical (Match Score 58) — or take the quiz to see where Next Vial lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Next Vial against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Next Vialthis provider | CoreAge Rxour #1 | Ascend Medicalclosest scorer |
|---|---|---|---|
| Sema price | $250/mo (compounded) | $149/mo | Not disclosed |
| Coverage | 49 states | All 50 states | 2 states |
| Formulary | Injectable | Injectable | Injectable |
| Match Score | 58 · C | 91 · A− | 58 · C |
Next Vial, answered
Is Next Vial legit?
Next Vial is a real, operating GLP-1 telehealth program, but we don't find it on the LegitScript registry, so it carries less third-party verification than the certified providers on our board. It dispenses compounded medication, which isn't FDA-approved. Vet the prescriber and pharmacy before you commit.
How much does Next Vial cost?
Next Vial lists compounded semaglutide from $250/mo (compounded) — above our category median of $179/mo. These are the provider's public figures at our last review (July 2026); confirm on their site, since some teaser tiers step up after month one.
Does Next Vial ship to my state?
Next Vial operates in a limited set of states (49 states). If yours isn't on that list, you'll need a nationwide provider instead.
Next Vial vs CoreAge Rx — which is better?
Both are on our board. Next Vial scores 58/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. Next Vial can still win for you if its strengths match your priorities — best for: People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified July 2026 from Next Vial's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Next Vial's site. Not medical advice; see our disclosure.
Next Vial earns a Match Score of 58/100 (grade C) and sits #333 of 497 on our board under the balanced default weighting. Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. Best for: People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner. If it isn't the right fit, Ascend Medical is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Next Vial on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Novi#334 | 58 | $174/mo (starting dose, compounded) | $283/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| NowPatient#335 | 58 | $1,349/mo (brand Wegovy) | $1,069/mo (brand Mounjaro, promotional rate) | Coverage not published | Alternatives | Visit |
| Obu Health#336 | 58 | $190/mo (starting dose, plus a separate fee, compounded) | $239/mo (starting dose, plus a separate fee, compounded) | Coverage not published | Alternatives | Visit |
| Somira Health#337 | 58 | $190/mo (compounded) | $285/mo (compounded) | Coverage not published | Alternatives | Visit |
| TD Tele-Doc Weight Loss#338 | 58 | Not disclosed | Not disclosed | 2 states | Alternatives | Visit |
| Unique Physique#339 | 58 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Bioverse#340 | 57 | $129/mo (starting dose, compounded) | $399/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| BodyLogicMD#341 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Call-On-Doc#342 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Elevated Health#343 | 57 | $296/mo (compounded) | $359/mo (compounded) | Coverage not published | Alternatives | Visit |
| Empower Pharmacy#344 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Eve#345 | 57 | $195/mo (compounded) | $195/mo (compounded) | Coverage not published | Alternatives | Visit |
| Hello Alpha#346 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Heros Health#347 | 57 | $199/mo (compounded) | $199/mo (compounded) | Coverage not published | Alternatives | Visit |
| Joi + Blokes#348 | 57 | $199/mo (promotional rate, quarterly plan, compounded) | $299/mo (quarterly plan, compounded) | Coverage not published | Alternatives | Visit |
| Luma Meds#349 | 57 | $249/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| Peptivo#350 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Revive Meds#351 | 57 | $369/mo (starting dose, compounded) | $459/mo (starting dose, compounded) | All 50 states | Alternatives | Visit |
| Rewinding RX#352 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Rivas Medical Weight Loss#353 | 57 | Not disclosed | Not disclosed | 3 states | Alternatives | Visit |
| Roboclinic#354 | 57 | $179/mo (12-month plan, compounded) | $299/mo (12-month plan, compounded) | Coverage not published | Alternatives | Visit |
| Signos#355 | 57 | $199/mo (6-month plan, compounded) | $199/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| TeleSlim Clinic#356 | 57 | Not disclosed | Not disclosed | 6 states | Alternatives | Visit |
| Voxy#357 | 57 | $179/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |